AU
Nuo Therapeutics, Inc.
AURX · OTC
$1.30 +4.83% (+$0.06)
1M +21.50%
Market Cap $62.9M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 12.10x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 209.05%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 64.11%
Net margin 38.70%
Op. margin 33.32%
Quality
21 /100
Poor ROIC 153.00%
ROA 76.63%
Asset turnover 1.98x
Debt
24 /100
High Current ratio 1.28x
Int. coverage -25.05x
Debt/Equity N/A
Stability
40 /100
Moderate Beta -104.09x
Rev. volatility 178.40%
EPS volatility 19.63%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre AURX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David E. Jorden
Employees
10
Headquarters
Houston
Evenimente viitoare
02 DEC.
Earnings
Upcoming earnings report